IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 4 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,398,000 | +58.5% | 2,500,000 | 0.0% | 0.05% | +41.7% |
| Q3 2019 | $6,560,000 | -4.8% | 2,500,000 | 0.0% | 0.04% | -5.3% |
| Q2 2019 | $6,888,000 | -27.7% | 2,500,000 | 0.0% | 0.04% | -35.6% |
| Q1 2019 | $9,530,000 | +33.2% | 2,500,000 | 0.0% | 0.06% | +25.5% |
| Q4 2018 | $7,154,000 | -30.8% | 2,500,000 | 0.0% | 0.05% | -17.5% |
| Q3 2018 | $10,338,000 | -12.0% | 2,500,000 | 0.0% | 0.06% | -20.8% |
| Q2 2018 | $11,743,000 | +60.3% | 2,500,000 | 0.0% | 0.07% | +50.0% |
| Q1 2018 | $7,324,000 | -9.5% | 2,500,000 | 0.0% | 0.05% | +17.1% |
| Q4 2017 | $8,096,000 | +14.6% | 2,500,000 | 0.0% | 0.04% | -25.5% |
| Q3 2017 | $7,065,000 | – | 2,500,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 4,614,000 | $19,166,000 | 0.22% |
| Calamos Advisors LLC | 2,500,000 | $10,398,000 | 0.05% |
| EVOKE WEALTH, LLC | 569 | $12,040,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |